Related Experiment Video
Updated: Jun 15, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Improving and assuring newborn screening laboratory quality worldwide: 30-year experience at the Centers for Disease
Víctor R De Jesús1, Joanne V Mei, Carol J Bell
1Newborn Screening Quality Assurance Program, Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA. vdejesus@cdc.gov
Insights
The Centers for Disease Control and Prevention
Area of Science:
- Public Health
- Genetics
- Clinical Diagnostics
Background:
- Newborn screening is a critical public health initiative in the U.S. for detecting inherited congenital disorders.
- Accurate and timely screening is essential to prevent long-term health issues in infants.
- The Centers for Disease Control and Prevention (CDC) plays a vital role in ensuring the quality of these screening programs.
Purpose of the Study:
- To review the milestones and services of the CDC's Newborn Screening Quality Assurance Program.
- To highlight the program's contribution to accurate and high-quality newborn screening.
- To underscore the program's role in supporting laboratories nationwide and globally.
Main Methods:
- The report reviews historical data and program evolution over 30 years.
- It details the services provided to enhance laboratory performance in newborn screening.
- Analysis of program growth in terms of disorders screened and participant laboratories.
Main Results:
- The CDC's Newborn Screening Quality Assurance Program has successfully supported screening for over 4 million infants annually.
- The program has expanded significantly, covering more than 50 disorders compared to 1 in 1978.
- It has consistently ensured accurate detection, minimized false positives, and maintained high-quality performance for participating laboratories.
Conclusions:
- The CDC's Newborn Screening Quality Assurance Program is a cornerstone of public health, safeguarding infant health through reliable genetic screening.
- The program's sustained growth and comprehensive services demonstrate its effectiveness and importance to the newborn screening community.
- Continued support and evolution of this program are crucial for addressing the challenges of inherited disorders in newborns.
Abstract:
Newborn screening is the largest population-based genetic screening effort in the United States. The detection of treatable, inherited congenital disorders is a major public health responsibility. The Centers for Disease Control and Prevention's (CDC's) Newborn Screening Quality Assurance Program helps newborn screening laboratories ensure that testing accurately detects these disorders, does not delay diagnosis, minimizes false-positive reports, and sustains high-quality performance. For over 30 years, the CDC's Newborn Screening Quality Assurance Program has performed this essential public health service, ensuring the quality and accuracy of screening tests for more than 4 million infants born each year in the United States and millions more worldwide. The Program has grown from 1 disorder in 1978 for 31 participants to more than 50 disorders for 459 participants in 2009. This report reviews the Program's milestones and services to the newborn screening community.
Related Concept Videos
Quality Control
Quality control helps track data, visualize trends, and identify variations, making it easier to detect deviations that may affect the accuracy of an analysis. One way to do this is by generating a quality control chart, which...
Automated Microbial Diagnostics
Investigation of Disease Outbreaks